What do systematic reviews say?

EGFR tyrosine kinase inhibitor (TKI) plus chemotherapy vs chemotherapy alone

The review found no eligible studies for this question.

• Epidermal growth factor receptor blockers for the treatment of ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Progestogen therapy (luteal phase only) vs other medical therapy

• Cyclical progestogens for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 62 participants
  Very low

Speech and language therapy vs healthy lifestyle advice

Speech and language therapy may leads to higher health‐related quality of life compared with healthy lifestyle advice (low certainty).

• Speech and language therapy for management of chronic cough 2019 · Cochrane Headline outcomes only
  MD 1.53 [0.21, 2.85]
  1 study · 71 participants
  Low

ICD plus optimal medical therapy vs optimal medical therapy alone

• Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 561 participants
  Moderate

Reminiscence therapy vs no treatment

• Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 1060 participants
  Moderate

Paradoxical intention therapy vs diazepam

The review found no eligible studies for this question.

• Psychosocial interventions for conversion and dissociative disorders in adults 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (combined ipilimumab and nivolumab) vs adjuvant immunotherapy (combined ipilimumab and nivolumab)

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (combined ipilimumab and nivolumab) vs neoadjuvant immunotherapy (nivolumab)

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Neoadjuvant immunotherapy (combined ipilimumab and nivolumab) vs neoadjuvant immunotherapy (sequential treatment with ipilimumab then nivolumab)

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transcutaneous electrical nerve stimulation (TENS) and standard urotherapy vs pelvic floor muscle training (PFMT) with electromyographic biofeedback and standard urotherapy

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 64 participants
  Very low

Surgery plus whole brain radiotherapy (WBRT) vs stereotactic radiosurgery plus WBRT

• Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 14 participants
  Very low

Surgery plus whole brain radiotherapy (WBRT) vs stereotactic radiosurgery

• Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1 participants
  Very low

Neoadjuvant immunotherapy (high dose interferon) plus chemotherapy vs neoadjuvant chemotherapy

The review found no eligible studies for this question.

• Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Reminiscence therapy vs no treatment

• Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 1037 participants
  High

Aromatherapy massage vs no massage

• Massage with or without aromatherapy for symptom relief in people with cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 29 participants
  Very low

Reminiscence therapy vs no treatment

• Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 193 participants
  Moderate

Reminiscence therapy vs no treatment

• Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 867 participants
  High

Endovascular revascularisation plus conservative therapy vs conservative therapy

• Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 330 participants
  Moderate

Summary of findings table ‐ Postmastectomy radiotherapy (PMRT) vs no PMRT

• Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes 2023 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Reminiscence therapy vs no treatment

• Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 23 participants
  Low